| Dougherty, James B. (Arcus Ventures 2007– General Partner + Co-founder) |
General Partner (venture partner) |
Arcus Ventures |
United States (USA) |
| Douglas, James (Exonhit– VP 200801 Corp Developm before Epigenomics 200601–200712 before Biosite) |
Business Development Manager / Strategy Manager |
Diaxonhit (Group) |
France |
| Dowdeswell, Christian (Lonza 201902 Head Dosage Forms + Delivery Systesm at Lonza Pharma & Biotech) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund) |
Investment Manager |
Debiopharm (Group) |
Switzerland |
| Doyle, Laurie (MC Services 201707 US) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Draetta, Francesco (Omega Funds 202010 Principal) |
Principal (venture capital) |
Omega Funds (Group) |
United States (USA) |
| Draheim, Henning (Boehringer Ingelheim 201111) |
Researcher (industry) |
Boehringer Ingelheim (Group) |
Germany |
| Drake, Richard (Medical Univ of South Carolina 201905 Professor + Director of Proteomics Center) |
Professor |
Medical University of South Carolina |
United States (USA) |
| Dranoff, Glenn (Novartis 201503– Head of new Immuno-oncology Research Group before Dana Farber) |
Researcher (industry) |
Novartis (Group) |
Switzerland |
| Drees, Ulrich (Boehringer Ingelheim 201301 Corporate SVP International Project Management) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Dreher, Christian (R-Biopharm 201907 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreher, Ralf (R-Biopharm 201111 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreiling, Thomas (Creathor Ventures 2017– PR + Communications before MSLGroup) |
Public Relations Manager / Investor Relations Manager |
Creathor Ventures (Group) |
Germany |
| Dreisewerd, Klaus (Univ Münster 201606 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Dreismann, Heiner (GeneNews 200810 Interim CEO + Lead Director before Roche Molecular Diagnostic CEO) |
Chief Executive Officer (CEO) |
GeneNews Ltd. (TSX: GEN) |
Canada |
| Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) |
Board member, executive |
Servier (Group) |
Denmark |
| Drescher, Thomas (DASGIP AG 201201 CEO) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Dreusch, Andrea B. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Dreusch, Andreas H.-J. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Drexhage, Karl H. (Atto-Tec 1999–) |
n. a. |
Atto-Tec GmbH |
Germany |
| Drexler, Mathias (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Driesen, Guido (Lonza 201612 CEO of Capsugel) |
Chief Executive Officer (CEO) |
Lonza (Group) |
United States (USA) |
| Driess, Matthias (TU Berlin 201008 Professor Dept of Chemistry) |
Professor |
Technical University Berlin (TU Berlin) |
Germany |
| Drijver, Alex (ChemAxon 200805 CEO before ThalesNano CEO + CFO before ComGenex CFO) |
Chief Executive Officer (CEO) |
ChemAxon (Group) |
Hungary |
| Dro, Philippe (LimmaTech Biologics 201505– before GlycoVaxyn CEO) |
Chief Executive Officer (CEO) |
LimmaTech Biologics AG |
Switzerland |
| Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners) |
Managing Partner (investment firm) |
Kurma (Group) |
France |
| Dromey, James (Murdochs Children Research Institute 201404 Head of Commercialisation) |
Sales Manager / Marketing Manager |
Murdoch Childrens Research Institute (MCRI) |
Australia |
| Dropulic, Boro (Lentigen 200601 Founder + CEO) |
Chief Executive Officer (CEO) |
Opus Bio Inc. |
United States (USA) |
| Drouet, Philippe (CRISPR Therapeutics 202102– Chief Commerical Officer before Merck & Co + Hospira + Novartis) |
Chief Commercial Officer (CCO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Drumm, Joshua (AC Immune 202003 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| du Buman, Jean-Luc (SGS 201609 Corp Developm + Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Dubilier, Nicole (Max Planck 201309– Director of MPI Bremen + Prof at Univ Bremen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Dubourg, Saori (BASF 201909 Executive Board Director) |
Board member, executive |
BASF (Group) |
Germany |
| Dubro, Claudia (Brandenburg (govt) 201912 Investment Manager at Brandenburg Kapital GmbH) |
Investment Manager |
Brandenburg (govt region) |
Germany |
| Dubruque, Samuel (Global Bioenergies 201710– CFO joined 2013 before Suez + Total) |
Chief Financial Officer (CFO) |
Global Bioenergies (Group) |
France |
| Dubuis, Benoît (Campus Biotech Geneva 201601 Site Director) |
President/Director/Head Business Group/Unit/Division |
Campus Biotech Innovation Center (Geneva, former Merck Serono site) |
Switzerland |
| Dubuis, Olivier (Viollier 201106) |
n. a. |
Viollier AG |
Switzerland |
| Duchemin, Jeffrey A. (Harvard Bioscience 201410 CEO) |
Chief Executive Officer (CEO) |
Harvard Bioscience (Group) |
United States (USA) |
| Duchesne de Lamotte, Hervé (ExonHit 200911– CFO before Cirrus Finance Management before IDM Paris) |
Chief Financial Officer (CFO) |
Diaxonhit (Group) |
France |
| Ducrey, Bertrand (Debiopharm 201610 CEO of Debiopharm International) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Switzerland |
| Duda, Maria (Genome Biologics (DE) 201810 Head of Business Development) |
Business Development Manager / Strategy Manager |
Genome Biologics UG |
Germany |
| Dufour, Sandrine (UCB 202007– CFO before Proximus + Vivendi + SFR) |
Chief Financial Officer (CFO) |
UCB (Group) |
Belgium |
| Dufresne, Claude (AxiVend LLC 201909 before Scienion) |
Chief Business Officer (CBO) |
AxiVend LLC |
United States (USA) |
| Dugi, Klaus (Boehringer 201106 Corporate SVP Medicine) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Duhr, Stefan (NanoTemper 201410 Managing Director + Co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Dulac, Emmanuel (Zealand Pharma 201909 CEO) |
Chief Executive Officer (CEO) |
Zealand Pharma (Group) |
Denmark |
| Dumitraskovic, Marion (Medicyte GmbH 201302 Sales + Marketing Manager) |
Sales Manager / Marketing Manager |
Medicyte GmbH |
Germany |
| Dumont, Jean-Maurice (Debiopharm 201504 VP Medical Affairs) |
Chief Medical Officer (CMO) |
Debiopharm (Group) |
Switzerland |
| Dunant, Nicolas (Roche 202002 Head Media Relations) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Switzerland |
| Duncan, Carri (Celyad 201810– VP CorpDev + Communications before Bayer + Egon Zehnder + Credit Suisse + Novartis) |
Business Development Manager / Strategy Manager |
Celyad (Group) |
Belgium |
| Dunlay, R. Terry (IntelliCyt 2016 CEO + Founder) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
United States (USA) |
| Duntze, Sabine (B3C Group GmbH 201104 Managing Director) |
Managing Director |
B3C Group GmbH |
Switzerland |
| Dupont-Inglis, Joanna (EuropaBio 201809– Secretary General) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Durack, Gary (iCyt 201002–<201206 CEO + Founder LEFT before 6/12) |
Chief Executive Officer (CEO) |
Sony (Group) |
United States (USA) |
| Durán, Cristina (AstraZeneca 201302– CFO at AstraZeneca GmbH before Finance Director at headquarters) |
Chief Financial Officer (CFO) |
AstraZeneca (Group) |
Germany |
| Durand, Nicolas (Abionic 201604 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abionic S.A. |
Switzerland |
| Durano, Jean-Marc (Meriéux 201106 Corporate VP Industrial Microbiology at bioMérieux) |
President/Director/Head Business Group/Unit/Division |
Mérieux (Group) |
France |
| Durham, Lynn (Stalicla 2017– CEO + Founder) |
Chief Executive Officer (CEO) |
Stalicla S.A. |
Switzerland |
| Durinx, Christine (Swiss Institute of Bioinformatics 202008 Executive Director) |
President/Director/Head of Research Organisation/Unit |
Swiss Institute of Bioinformatics (SIB) |
Switzerland |
| Durner, Roland (Tecan 200711 Market Manager) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Durst, Roger (Bruker Corp 201512 CTO + General Manager of Crystallography at Bruker AXS) |
Chief Technology/Technical Officer (CTO) |
Bruker (Group) |
Germany |
| Dusek, Alex (Erytech 201805– VP Commercial Strategy before Argos Therapeutics + Bayer HealthCare + United Therapeutics) |
Business Development Manager / Strategy Manager |
Erytech (Group) |
United States (USA) |
| Duss, Jonas (Kaia Health 202012 US CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Kaia Health (Group) |
United States (USA) |
| Duvall, Jean (Ferring 201912 Executive Board Member of Ferring Pharmaceuticals + Co-Chair of FerGene) |
Board member, executive |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Dübel, Stefan (TU Braunschweig 201912 Professor for Biotechnology) |
Professor |
Technical University Braunschweig (TU Braunschweig) |
Germany |
| Düchting, Matthias (Hamilton Robotics 200704 International Sales Director) |
Sales Manager / Marketing Manager |
Hamilton (Group) |
Switzerland |
| Dyck, Joachim (Yaya Diagnostics 201311– Managing Director before AnagnosTec + Chimera Biotec) |
Managing Director |
Yaya Diagnostics GmbH |
Germany |
| Dyer, Tim (Addex CEO 201802 formerly CFO + Co-Founder) |
Chief Executive Officer (CEO) |
Addex (Group) |
Switzerland |
| Dylan-Hyde, Tyler (CRISPR Therapeutics 201703 Chief Legal Officer) |
General Counsel / Chief Legal Officer (CLO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Düllmann, Peter (Sal. Oppenheim 200305–200809– Analyst) |
Analyst (Financial / Industry) |
Sal. Oppenheim (Group) |
Germany |
| Dymaszewski, Claudia (Caliper Life Sciences 200809 Caliper Germany) |
Sales Manager / Marketing Manager |
BioFluidix GmbH |
Germany |
| Dünwald, Christoph (Biofrontera 201511– CCO before Allergan + Corporacion Dermoestetica + Bayer) |
Chief Commercial Officer (CCO) |
Biofrontera (Group) |
Germany |
| Dyrberg, Thomas (Novo 201105 Senior Partner Novo Ventures) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Düx, Petra |
n. a. |
Berlin (govt region) |
Germany |
| Däbritz, Frank (UGA Biopharma GmbH 201708 Marketing + Sales) |
Sales Manager / Marketing Manager |
UGA Biopharma GmbH |
Germany |
| Dähne, Lars (Surflay Nanotec GmbH 201008– Managing Director + Founder before 200803 Project Manager at Capsulution) |
Managing Director |
Capsulution (Group) |
Germany |
| Döbelin, Werner (Prolab GmbH 199605– Managing Director + Owner) |
Managing Director |
Prolab GmbH (CH) |
Switzerland |
| Döhmen, Stefan (Analytik Jena 200606 CFO) |
Chief Financial Officer (CFO) |
Endress+Hauser (Group) |
Germany |
| Döring, Martina (aevotis 201011 Managing Director) |
Managing Director |
Advanced Enzyme Technologies (Advanced Enzymes) (Group) |
Germany |
| Dörner, Wolfgang (Scientific Devices Heidelberg 201107 Managing Director) |
Managing Director |
Scientific Devices Heidelberg GmbH |
Germany |
| D’Augusta, Claudia (TiGenix 201204 CFO) |
Chief Financial Officer (CFO) |
Takeda (Group) |
Belgium |
| D’Cruz, Cony (Proteros 201008– CBO + President Proteros US Inc before Evotec SVP North America) |
Chief Business Officer (CBO) |
Proteros (Group) |
United States (USA) |
| d’Epenoux, Pierre (ImCheck Therapeutics 201705– CEO) |
Chief Executive Officer (CEO) |
ImCheck Therapeutics S.A.S. |
France |
| d’Hauteville, Guillaume (Access Industries 201710 Vice Chairman) |
n. a. |
Access Industries (Group) |
United States (USA) |
| D’Silva, Kyle (Thermo Fisher 2010604 Pharma & Biopharma Marketing) |
Product Manager (personnel) |
Thermo Fisher Scientific, Hemel Hempstead |
United Kingdom (GB) |
| Eastham, Karin (Board Director at MorphoSys + Illumina + Amylin + Trius + Geron) |
Board member, non-executive |
MorphoSys (Group) |
Germany |
| Ebeling, Thomas (UBS 201711 Standing Member of UBS Oncology Impact Fund former Novartis Pharma CEO) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
UBS (Group) |
United Kingdom (GB) |
| Eberle, Eckard (Siemens 201506 CEO of Process Automation business unit) |
Chief Executive Officer (CEO) |
Siemens Process Automation business unit |
Germany |
| Eberle, Sandra (Stratec 201607 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Stratec (Group) |
Germany |
| Eberlein, Robert (Sartorius 201603 Managing Director Sartorius Group Latin America) |
Regional manager |
Sartorius (Group) |
Germany |
| Ebli, Michael (Greiner Tool.Tec 200803 CEO) |
Chief Executive Officer (CEO) |
Greiner (Group) |
Austria |
| Ebner, Christoph (Anton Paar 201311 Business Developm Manager + General Manager of CSM Instruments) |
Business Development Manager / Strategy Manager |
Anton Paar (Group) |
Austria |
| Ebsworth, David (Galenica 200910–201508 CEO Vifor Pharma RETIRES 8/14 before OGS CEO + Bayer Head Pharma |
Board member, non-executive |
Verona Pharma (Group) |
United Kingdom (GB) |
| Echeverri, Christophe (Cenix BioScience 200502 CEO + CSO) |
Chief Executive Officer (CEO) |
Cenix BioScience (Group) |
Germany |
| Eck, Jürgen (BRAIN 201507–201912 CEO before CTO + Co-founder LEFT 1/20) |
Chief Executive Officer (CEO) |
BRAIN (Group) |
Germany |
| Eckert, Andreas (Eckert & Ziegler) |
n. a. |
Eckert & Ziegler (Group) |
Germany |
| Eckes, Peter (BASF 201201 President of BASF Plant Science) |
President/Director/Head Business Group/Unit/Division |
BASF (Group) |
Germany |
| Eckhardt, Annette (Xtal Concepts 201208 Managing Director) |
Managing Director |
Xtal Concepts GmbH |
Germany |
| Eckhardt, Dominik (Miltenyi Biotec 201901 RnD Manager) |
Research & Development Manager |
Miltenyi Biotec (Group) |
Germany |
| Eckhardt, Jürg (Bellevue 201108) |
Investment Manager |
Bellevue (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 14 15 16 ... 73 74 75 
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
